|
HE 20.6524:119
|
Perinatal depression prevalence, screening accuracy, and screening outcomes / |
1 |
|
HE 20.6524:119/SUM
|
Perinatal depression prevalence, screening accuracy, and screening outcomes / |
1 |
|
HE 20.6524:120
|
Management of menopause-related symptoms |
1 |
|
HE 20.6524:120/SUM
|
Management of menopause-related symptoms |
1 |
|
HE 20.6524:121
|
Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD) |
1 |
|
HE 20.6524:121/SUM
|
Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD) |
1 |
|
HE 20.6524:122
|
Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials |
1 |
|
HE 20.6524:122/SUM
|
Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials |
1 |
|
HE 20.6524:123
|
Post-myocardial infarction depression |
1 |
|
HE 20.6524:123/SUM
|
Post-myocardial infarction depression |
1 |
|
HE 20.6524:124
|
Update on acute bacterial rhinosinusitis |
1 |
|
HE 20.6524:124/SUM
|
Update on acute bacterial rhinosinusitis |
1 |
|
HE 20.6524:125
|
Manifestations and management of chronic insomnia in adults |
1 |
|
HE 20.6524:125/SUM
|
Manifestations and management of chronic insomnia in adults |
1 |
|
HE 20.6524:126
|
Effects of soy on health outcomes |
1 |
|
HE 20.6524:126/SUM
|
Effects of soy on health outcomes |
1 |
|
HE 20.6524:127
|
Acute stroke evaluation and treatment / |
1 |
|
HE 20.6524:127/SUM
|
Acute stroke evaluation and treatment / |
1 |
|
HE 20.6524:128
|
Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose |
1 |
|
HE 20.6524:128/SUM
|
Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose |
1 |
